Forget worms—save $300 with early-bird Owner Summit registration
Published January 19, 2024
The professional development event of the year for compounding pharmacy and facility owners and managers is back, and it’s better than ever.
APC News
They don’t know what they don’t know
Published January 19, 2024
It was another week of interesting reporting on GLP-1s—compounded, counterfeit, and commercially available. APC continues to field multiple media inquiries each week about the GLP-1 craze and compounding’s role in shortages.
New tools to educate prescribers on cBHT threat
Published January 12, 2024
We’ve got some new tools to help you educate and inform prescribers about the threat to compounded hormone therapy.
APC to FDA: Show your work (please?)
Published January 12, 2024
APC submitted comments this week on FDA’s Interim Policy on Compounding Using Bulk Drug Substances Under Section 503A of the Federal Food, Drug, and Cosmetic Act.
APC leaders talk MOU and more in FDA listening session
Published January 12, 2024
In a listening session with representatives from FDA’s Center for Drug Evaluation & Research this week, APC leaders again pressed FDA to support a proposal to eliminate the MOU on interstate shipments of compounded medications.
You say goodbye, I say hello …
Published January 12, 2024
This week, just two weeks into the new year, in a special-called APC Board of Directors meeting, I resigned as your 2024 APC Board Chair effective January 31. On February 1, I will join the APC staff as Chief Advocacy Officer.
Scam Alert: Beware (and be aware).
Published January 5, 2024
Pharmacies across the country have been flooded with the fax pictured below. Thing is, it’s a scam.
APC submits comments for Senate hearing on drug shortages
Published January 5, 2024
On December 5, APC submitted comments to the Senate Finance Committee for a hearing on drug shortages.
PCF awards 8 compounding education grants to state associations
Published January 5, 2024
The Pharmacy Compounding Foundation has awarded $1,500 compounding education grants to eight state pharmacy associations for 2024.
Tell us what didn’t work for you
Published January 5, 2024
APC’s fourth annual Owner Summit April 4-6 in LaJolla, Calif., will include a session called “Don’t Bother: Things Not to Try.”
We’ve got a story to tell
Published January 5, 2024
Happy new year! Thanks to what we achieved in 2023 — especially our membership revenue growth — we’re well positioned to do even more in 2024.
Your unrelenting desire to do right by your patients
Published December 15, 2023
As we prepare to celebrate the end of one year and the beginning of another, it seems like a natural time for us all to reflect on what we accomplished in 2023.
First pharmacy onboarded with APC credit card processing GPO
Published December 15, 2023
Christmas has come early for pharmacy owner Jack Korbutov.
Revelation, Empower commit as Diamond-level APC sponsors
Published December 15, 2023
Revelation Pharma and Empower have joined Medisca as Diamond-level corporate patrons for 2024.
Introducing: New prescriber education tools on cBHT threat
Published December 15, 2023
We’ve got some new tools especially designed to help you educate and inform prescribers about the threat to compounded hormone therapy.
APC files amicus in Lilly case against Revive RX
Published December 15, 2023
APC filed an amicus brief in the Eli Lilly v. Revive RX case in the Southern District of Texas last week.
Got BOP emails? Share, please.
Published December 8, 2023
Admitting you have a problem is the first step, they say. Well APC has a problem, and we’re looking for you to help us solve it.
National reporters tour Preston’s Pharmacy
Published December 8, 2023
It was supposed to be an hour-long tour, but with their questions, it lasted for about two hours.
FDA to end bulk drug categories
Published December 8, 2023
This week, FDA published a new draft guidance. If finalized as presented, FDA will no longer categorize items for the bulks drug list prior to evaluating them for inclusion.
A few sips
Published December 7, 2023
This week’s column from CEO Scott Brunner is like a potpourri, a mixture. Drink up.
PCF names new directors
Published December 1, 2023
The Pharmacy Compounding Foundation has elected five board members
Our state-by-state 795-797-800 chart has been updated
Published December 1, 2023
APC has posted an updated version of our compilation of state by state adoption of USP <795>, <797>, and <800>.
Novo alleges potency discrepancy, impurities in compounded semaglutide
Published December 1, 2023
We’ll let you read it for yourself. Interesting how the reporter seems to take Novo’s word for it, no?
APC files amicus in Novo case against Tennessee compounder
Published December 1, 2023
A U.S. District Court judge approved APC filing an amicus brief this week in Novo Nordisk’s lawsuit against Tennessee compounder (and APC PFM) DCA Pharmacy.
A $100,000 deficit
Published December 1, 2023
One of the challenges of being an ambitious but resource-poor association is that we have to spend a lot of time asking members like you for money.
Telling your story, one reporter at a time
Published November 30, 2023
The photo inset below on the left was taken last Friday morning at Preston’s Pharmacy (a PFM, I might add) in Arlington, Virginia. It’s not a pharmacist or technician in the photo. It’s a healthcare reporter.
There’s a lot you can learn from errors
Published November 30, 2023
Patient safety is job one in any pharmacy, but especially in compounding pharmacies. So on those rare occasions when errors occur — in your pharmacy or someone else’s — you want to be able to learn from them.
What does FD&C Act really say about USP compliance?
Published November 30, 2023
In response to inquiries from state boards of pharmacy regarding the enforceability of revised USP Chapters <795>, <797>, and <800>, a recent memo aims to clarify references in the Food, Drug & Cosmetic Act.
Letter seeks clarity on semaglutide compounding in California
Published November 30, 2023
Last week, we sent a letter to the California Board of Pharmacy requesting clarification of its position on compounding semaglutide.
There’s a committee for that
Published November 30, 2023
APC is recruiting committee members for 2024.
